Non-Coding RNAs in Diagnostic Pathology of High-Grade Central Osteosarcoma

Area of Science:

• Oncology
• Molecular Biology
• Genetics

Background:

• Histological evaluation is the standard for diagnosing highly malignant osteosarcoma but has limitations, leading to misdiagnoses and inadequate treatments.
• Current adjunct methods like immunohistochemistry and molecular genetics have limited utility for osteosarcoma due to complexity and specificity issues.
• Non-coding RNAs (ncRNAs) are gaining attention in cancer diagnostics, with altered expression patterns differentiating benign and malignant tumors in various organs.

Purpose of the Study:

• To review the current status of non-coding RNAs in osteosarcoma diagnostics.
• To evaluate the potential of ncRNA expression patterns as an adjunct to histological evaluation for improving osteosarcoma diagnosis.
• To discuss the preliminary findings and future directions of ncRNA applications in bone tumor diagnostics.

Main Methods:

• Literature review of studies on non-coding RNAs (microRNAs) in osteosarcoma diagnosis.
• Analysis of existing data on the diagnostic utility of ncRNA expression patterns in bone tumors.
• Comparison of ncRNA-based diagnostics with traditional histological and molecular genetic approaches.

Main Results:

• Divergent microRNA expression has shown utility in differentiating osteosarcoma from osteoblastoma and other bone tumors like giant-cell tumors and fibrous dysplasia.
• While promising, the application of ncRNA expression patterns for osteosarcoma differential diagnosis is still in preliminary stages.
• The complexity of molecular genetic alterations in osteosarcoma limits their diagnostic utility, highlighting the need for novel approaches.

Conclusions:

• Non-coding RNAs represent a promising area for enhancing the diagnostic security of highly malignant osteosarcoma.
• Integrating ncRNA expression analysis with histological evaluation could significantly improve diagnostic accuracy and patient outcomes.
• Further research is needed to fully elucidate and validate the role of ncRNAs in osteosarcoma diagnostics.